Embryonic stem cells go from bench to bedside for Parkinson's disease
Clare L Parish, Lachlan H Thompson
Cell Reports Medicine | ELSEVIER | Published : 2021
Stem-cell-derived transplants may soon be a promising treatment option for Parkinson's disease. In preparation for clinical trial, Piao et al.1 report on generating a clinical-grade dopaminergic progenitor cell product and its rigorous testing to ensure safety and efficacy.